
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1027 | 1036 | 1053 | 1058 | 1191 | 2067 |
Fund Return | 2.68% | 3.64% | 5.29% | 1.89% | 3.55% | 7.53% |
Place in category | 346 | 315 | 335 | 227 | 165 | 24 |
% in Category | 86 | 83 | 92 | 72 | 59 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Liontrust Special Situations Fund R | 29.78M | 1.87 | -1.97 | 6.72 | ||
Liontrust Special Situations Fund I | 1.7B | -0.13 | 2.54 | 7.04 | ||
Liontrust European Growth Fund A In | 9.29M | 7.91 | 10.00 | 12.06 | ||
Liontrust European Growth Fund I In | 764.81M | 8.55 | 11.51 | 12.26 | ||
GB0030030067 | 888.63M | 8.83 | -0.44 | 11.54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund I Acc | 1.82B | 5.76 | 12.94 | 9.93 | ||
Artemis UK Select Fund G Inc GBP | 792.5M | 5.79 | 13.25 | - | ||
Artemis UK Select Fund R Acc | 221.92M | 5.69 | 12.10 | 9.10 | ||
Artemis UK Select Fund I Inc GBP | 215.18M | 25.31 | 10.43 | 9.44 | ||
Fidelity Special Situations Fund W | 3.24B | 3.77 | 8.82 | 7.98 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 3.73 | 11,544.0 | +0.56% | |
Shell | GB00BP6MXD84 | 3.57 | 30.60 | +0.30% | |
Relx | GB00B2B0DG97 | 3.50 | 3,646.00 | -0.27% | |
BP | GB0007980591 | 3.43 | 412.95 | +0.30% | |
Unilever | GB00B10RZP78 | 3.40 | 54.42 | +0.15% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review